Triglycerides, fatty acids and insulin resistance - Hyperinsulinemia

Experimental and Clinical Endocrinology and Diabetes

Volumn 109, Issue 4, 2001, Pages

  Kraegen, E W ^a   Cooney, G J ^a   Ye, J ^a   Thompson, A L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

High fat diet; Lipids; Muscel; Thiazolidinediones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACYL COENZYME A; ANTILIPEMIC AGENT; FATTY ACID; FIBRIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; TRIACYLGLYCEROL;

CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID STORAGE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; SYNDROME X;

EID: 0034968074     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15114     Document Type: Conference Paper

References (111)

1. What if Minkowski had been ageusic? An alternative angle on diabetes
2. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
3. Effects of lipids on blood glucose regulation and insulin action
4. Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years
5. Influence of dietary fat composition on development of insulin resistance in rats
6. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats
7. Thiazolidinediones in the treatment of insulin resistance and Type II diabetes
8. Peroxisome proliferator-activated receptors and the regulation of lipid oxidation and adipogenesis
9. PPAR-Gamma - Adipogenic regulator and thiazolidinedione receptor
10. Peroxisome proliferator-activated receptors, orphans with ligands and functions
11. Treatment of lipid disorders in non-insulin dependent diabetes mellitus
12. Comparative study on the in vivo and in vitro antilipolytic effects of etofibrate, nicotinic Acid and clofibrate in the rat
13. Choosing the right lipid-regulating agent - A guide to selection
14. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
15. Malonyl-CoA, fuel sensing, and insulin resistance
16. Are the beta -cell signalling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM
17. Tumor necrosis factor alpha - A key component of the obesity - Diabetes link
18. Direct antidiabetic effect of Leptin through triglyceride depletion of tissues
19. Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice
20. Leptin directly alters lipid partitioning in skeletal muscle
21. Five hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
22. Free fatty acid-induced insulin resistance is associated wth activation of protein kinase C theta and alterations in the insulin signaling cascade
23. Operation of Randle's cycle in patients with NIDDM
24. Effect of elevated free fatty acids on glucose oxidation in normal humans
25. Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo
26. Effects of fat on insulin stimulated carbohydrate metabolism in normal men
27. Mechanisms of fatty acid induced inhibition of glucose uptake
28. Interaction between glucose and free fatty acid metabolism in human skeletal muscle
29. Prolonged suppression of glucose metabolism causes insulin resistance in rat skeletal muscle
30. C-13 and P-31 NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat
31. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise - Parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA
32. Effects of high fat-feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme-A esters in liver and skeletal muscle
33. Development of insulin resistance in the jcr-La-Cp rat - Role of triacylglycerols and effects of Medica 16
34. Role of muscle in triglyceride metabolism
35. Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients
36. Long-chain acyl-CoA esters as indicators of lipid availability and insulin sensitivity in rat and human muscle
37. Skeletal muscle triglyceride levels are inversely related to insulin action
38. Intramuscular triglyceride and muscle insulin sensitivity - Evidence for a relationship in nondiabetic subjects
39. In vivo determination of intra-myocellular lipids in human muscle by means of localized H-1-MR-Spectroscopy
40. Measurement of intracellular triglyceride stores by 1-H spectroscopy: Validation in liver and skeletal muscle in vivo
41. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A H-1 NMR spectroscopy study
42. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of Type 2 diabetic subjects
43. Design of the oxygen and substrate pathways. V. structural basis of vascular substrate supply to muscle cells
44. Analysis of acyl-Coenzyme A esters in biological samples
45. Relationship of insulin sensitivity with abdominal fat and muscle long chain acyl CoA (LCAC) in men
46. Abdominal fat and insulin resistance in normal and overweight women - Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM
47. Intra-abdominal fat is associated with decreased insulin sensitivity in healthy young men
48. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women
49. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women
50. Is visceral fat (intra-abdominal and hepatic) a major determinant of gender differences in insulin resistance and dyslipidemia?
51. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat
52. Skeletal muscle utilization of free fatty acids in women with visceral obesity
53. Cardiac and femoral muscle FFA uptake in patients with IGT or NIDDM as studied with 14(R,S)-[18F]fluoro-6-thiaheptadecanoic acid and PET
54. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria
55. Metabolic interactions between glucose and fatty acids in humans
56. Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats
57. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat
58. Functional differences in lipid metabolism in resting skeletal muscle of various fiber types
59. Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer
60. Effects of an oral and intravenous fat load on adipose tissue and forearm lipid metabolism
61. Non-esterified fatty acid metabolism and postprandial lipaemia
62. Postprandial triglyceride high response and the metabolic syndrome
63. Mechanisms decreasing glucose oxidation in diabetes and starvation: Role of lipid fuels and hormones
64. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding
65. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and cell signalling
66. Fatty acid oxidation intermediates and the effect of fasting on oxidation in red and white skeletal muscle
67. A malonyl-CoA fuel-sensing mechanism In muscle - Effects of insulin, glucose, and denervation
68. Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase
69. An allosteric model for the inhibition of glucokinase by long acyl coenzyme A
70. Fatty acyl-CoA esters inhibit glucose-6-phosphatase in rat liver microsomes
71. Inhibitory effects of long-chain acyl coenzyme A analogues on liver acetyl coenzyme A carboxylase
72. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis
73. Inhibition of hormone-sensitive lipase by intermediary lipid metabolites
74. Activation of protein kinase C alpha inhibits signalling by members of the insulin receptor family
75. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat
76. Intracellular translocation of phosphatide phosphohydrolase and its possible role in the control of glycerolipid synthesis
77. Dietary fat, genes and human health
78. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues
79. Peroxisome proliferatoractivated receptors: A nuclear receptor signaling pathway in lipid physiology
80. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α
81. Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion
82. Dietary fats, membrane phospholipids and obesity
83. The relation between insulin sensitivity and the fatty acid composition of skeletal-muscle phospholipids
84. Fatty acids, triglycerides and syndromes of insulin resistance
85. Dietary fats and insulin action
86. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR-gamma)
87. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
88. Skeletal muscle peroxisome proliferator-activated receptor-gamma expression in obesity and non-insulin-dependent diabetes mellitus
89. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat
90. Effects of a 48-h fat infusion on insulin secretion and glucose utilization
91. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs
92. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo
93. The insulin sensitizer BRL49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat
94. Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed Rats by BRL-49653
95. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
96. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
97. Acute and chronic effects of Troglitazone (CS-045) on isolated rat ventricular cardiomyocytes
98. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese Type II diabetic subjects
99. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats
100. Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in wistar fatty rats
101. Short-term exposure to tumor necrosis factor alpha does not affect insulin-stimulated glucose uptake in skeletal muscle
102. TNF-alpha-induced insulin resistance in vivo and its prevention by Troglitazone
103. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPAR delta ligands produce distinct biological effects
104. Improved insulin sensitivity by bezafibrate in rats - Relationship to fatty acid composition of skeletal-muscle triglycerides
105. Effect Of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats
106. Impact of nicotinic acid treatment on insulin secretion and insulin sensitivity in low and high insulin responders
107. The prediabetic problem - Development of noninsulin dependent diabetes mellitus and associated abnormalities
108. The effect of 24-hour suppression of plasma non-esterified fatty acid levels on glucose and lipid metabolism in NIDDM
109. Effects Of acipimox on the metabolism of free fatty acids and very low density lipoprotein triglyceride
110. Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in Man
111. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma. Effect of PPARalpha activation on abnormal lipid metabolism in liver of Zucker Fatty rats